Stock Analysts’ Price Target Changes for November 4th (ADM, AME, AMGN, ASBH, BKNG, BMRN, CALX, CAMT, CRSP, CRWV)

Stock Analysts’ price target changes for Wednesday, November 4th:

Archer Daniels Midland (NYSE:ADM) had its price target lowered by Stephens from $85.00 to $75.00. The firm currently has an equal weight rating on the stock.

AMETEK (NYSE:AME) had its price target raised by Citigroup from $263.00 to $270.00. The firm currently has a neutral rating on the stock.

Amgen (NASDAQ:AMGN) had its target price raised by Citigroup from $405.00 to $465.00. They currently have a neutral rating on the stock.

American Savings Bank of Hawaii (NYSE:ASBH) had its target price boosted by Stephens from $21.00 to $22.00. They currently have an overweight rating on the stock.

Booking (NASDAQ:BKNG) had its target price trimmed by JPMorgan Chase & Co. from $248.00 to $205.00. The firm currently has an overweight rating on the stock.

Booking (NASDAQ:BKNG) had its price target trimmed by Citigroup from $236.00 to $220.00. The firm currently has a buy rating on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its target price cut by JPMorgan Chase & Co. from $87.00 to $86.00. They currently have an overweight rating on the stock.

Calix (NYSE:CALX) had its price target trimmed by JPMorgan Chase & Co. from $58.00 to $50.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Camtek (NASDAQ:CAMT) had its target price reduced by Needham & Company LLC from $170.00 to $130.00. They currently have a buy rating on the stock.

CRISPR Therapeutics (NASDAQ:CRSP) had its price target increased by Citigroup from $88.00 to $90.00. They currently have a buy rating on the stock.

CoreWeave (NASDAQ:CRWV) had its target price lowered by Citigroup from $159.00 to $128.00. They currently have a buy rating on the stock.

Duolingo (NASDAQ:DUOL) had its target price increased by Citigroup from $140.00 to $152.00. Citigroup currently has a neutral rating on the stock.

Flutter Entertainment (NYSE:FLUT) had its target price boosted by BTIG Research from $95.00 to $96.00. The firm currently has a buy rating on the stock.

GlobalFoundries (NASDAQ:GFS) had its price target reduced by Needham & Company LLC from $80.00 to $55.00. Needham & Company LLC currently has a buy rating on the stock.

Hamilton Lane (NASDAQ:HLNE) had its target price lowered by JPMorgan Chase & Co. from $150.00 to $144.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

CarMax (NYSE:KMX) had its price target lowered by JPMorgan Chase & Co. from $70.00 to $65.00. They currently have a neutral rating on the stock.

Neutron (NASDAQ:LIME) had its target price lowered by JPMorgan Chase & Co. from $38.00 to $33.00. The firm currently has an overweight rating on the stock.

Nebius Group (NASDAQ:NBIS) had its price target lowered by Citigroup from $324.00 to $265.00. Citigroup currently has a buy rating on the stock.

onsemi (NASDAQ:ON) had its target price reduced by Citigroup from $98.00 to $80.00. Citigroup currently has a neutral rating on the stock.

Oportun Financial (NASDAQ:OPRT) had its target price increased by Stephens from $12.00 to $14.00. The firm currently has an overweight rating on the stock.

Pfizer (NYSE:PFE) had its price target increased by Citigroup from $27.00 to $30.00. Citigroup currently has a neutral rating on the stock.

Performance Food Group (NYSE:PFGC) had its price target boosted by TD Cowen from $110.00 to $125.00. TD Cowen currently has a buy rating on the stock.

People Incorporated Common Stock (NASDAQ:PPLI) had its target price trimmed by Citigroup from $52.00 to $47.00. The firm currently has a buy rating on the stock.

Red Rock Resorts (NASDAQ:RRR) had its target price trimmed by JPMorgan Chase & Co. from $71.00 to $64.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Revvity (NYSE:RVTY) had its target price raised by JPMorgan Chase & Co. from $155.00 to $160.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Sonic Automotive (NYSE:SAH) had its price target reduced by JPMorgan Chase & Co. from $63.00 to $58.00. The firm currently has an underweight rating on the stock.

Sotera Health (NASDAQ:SHC) had its price target reduced by JPMorgan Chase & Co. from $17.00 to $15.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.

Sportradar Group (NASDAQ:SRAD) had its price target trimmed by JPMorgan Chase & Co. from $13.00 to $12.00. They currently have a neutral rating on the stock.

Stevanato Group (NYSE:STVN) had its price target lowered by Citigroup from $26.00 to $20.00. The firm currently has a buy rating on the stock.

LendingTree (NASDAQ:TREE) had its price target trimmed by JPMorgan Chase & Co. from $48.00 to $40.00. The firm currently has an overweight rating on the stock.

Thomson Reuters (NASDAQ:TRI) had its price target increased by JPMorgan Chase & Co. from $110.00 to $115.00. The firm currently has a neutral rating on the stock.

UL Solutions (NYSE:ULS) had its target price trimmed by Citigroup from $82.80 to $81.40. They currently have a neutral rating on the stock.

Viridian Therapeutics (NASDAQ:VRDN) had its price target boosted by Needham & Company LLC from $34.00 to $38.00. They currently have a buy rating on the stock.

Versant (NASDAQ:VSNT) had its target price trimmed by JPMorgan Chase & Co. from $43.00 to $39.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Waters (NYSE:WAT) had its target price raised by JPMorgan Chase & Co. from $435.00 to $470.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Xometry (NASDAQ:XMTR) had its target price raised by JPMorgan Chase & Co. from $120.00 to $140.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Xometry (NASDAQ:XMTR) had its target price boosted by Citigroup from $110.00 to $132.00. The firm currently has a buy rating on the stock.

ExxonMobil (NYSE:XOM) had its price target raised by Citigroup from $155.00 to $175.00. Citigroup currently has a neutral rating on the stock.

CLEAR Secure (NYSE:YOU) had its price target raised by Needham & Company LLC from $70.00 to $90.00. The firm currently has a buy rating on the stock.

Zebra Technologies (NASDAQ:ZBRA) had its price target lowered by Citigroup from $400.00 to $398.00. They currently have a neutral rating on the stock.